BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 4008982)

  • 1. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid).
    Briggaman RA; Gammon WR; Woodley DT
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):79s-84s. PubMed ID: 4008982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
    Woźniak K; Kowalewski C
    J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human skin basement membrane in health and in autoimmune diseases.
    Chan LS
    Front Biosci; 1997 Jul; 2():d343-52. PubMed ID: 9232815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidermal basement membrane zone--structure, ontogeny, and role in disease.
    Katz SI
    J Am Acad Dermatol; 1984 Dec; 11(6):1025-37. PubMed ID: 6512049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens: differences in organ and species specificities and localization in chemically-separated human skin of three basement membrane antigens.
    Fine JD
    Coll Relat Res; 1985 Sep; 5(4):369-77. PubMed ID: 3902344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping.
    De Jong MC; Bruins S; Heeres K; Jonkman MF; Nieboer C; Boorsma DM; Pas HH; van der Meer JB
    Arch Dermatol; 1996 Feb; 132(2):151-7. PubMed ID: 8629822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.
    Gammon WR; Briggaman RA; Inman AO; Queen LL; Wheeler CE
    J Invest Dermatol; 1984 Feb; 82(2):139-44. PubMed ID: 6363567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen.
    Gammon WR; Woodley DT; Dole KC; Briggaman RA
    J Invest Dermatol; 1985 Jun; 84(6):472-6. PubMed ID: 3889170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermolysis bullosa acquisita--a pemphigoid-like disease.
    Gammon WR; Briggaman RA; Woodley DT; Heald PW; Wheeler CE
    J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):820-32. PubMed ID: 6392361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
    Fine JD
    J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood epidermolysis bullosa acquisita. Detection in a 5-year-old girl.
    Rubenstein R; Esterly NB; Fine JD
    Arch Dermatol; 1987 Jun; 123(6):772-6. PubMed ID: 3555356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermolysis bullosa acquisita: a clinical disorder of varied etiologies. Two cases and a review of immunologic and other reported findings.
    Wilson BD; Birnkrant AF; Beutner EH; Maize JC
    J Am Acad Dermatol; 1980 Sep; 3(3):280-91. PubMed ID: 7005274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double immunofluorescence microscopy: a method for localizing immune deposits in skin diseases associated with linear basement membrane zone immunofluorescence.
    Gammon WR; Robinson T; Briggaman RA; Wheeler CE
    J Invest Dermatol; 1982 Nov; 79(5):312-7. PubMed ID: 6752293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen.
    Paller AS; Queen LL; Woodley DT; Gammon WR; O'Keefe EJ; Briggaman RA
    J Invest Dermatol; 1985 Mar; 84(3):215-7. PubMed ID: 3882847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting.
    Kirtschig G; Wojnarowska F; Marsden RA; Edwards S; Bhogal B; Black MM
    Br J Dermatol; 1994 May; 130(5):610-6. PubMed ID: 8204469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR; Inman AO; Wheeler CE
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
    Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita.
    Peng TK; Nisengard RJ; Levine MJ; Beutner EH
    Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid.
    Wieme N; Lambert J; Moerman M; Geerts ML; Temmerman L; Naeyaert JM
    Dermatology; 1999; 198(3):310-3. PubMed ID: 10393462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.